Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             36 results found
no title author magazine year volume issue page(s) type
1 Acute disseminated encephalomyelitis complicating dengue infection with neuroimaging mimicking multiple sclerosis: A report of two cases Viswanathan, S.
2016
10 C p. 112-115
4 p.
article
2 Association between exposure to farm animals and pets and risk of Multiple Sclerosis Siejka, Dylan
2016
10 C p. 53-56
4 p.
article
3 A study of cognitive fatigue in Multiple Sclerosis with novel clinical and electrophysiological parameters utilizing the event related potential P300 Chinnadurai, Somasundaram Aadhimoolam
2016
10 C p. 1-6
6 p.
article
4 A systematic review of anxiety amongst people with Multiple Sclerosis Butler, Ellen
2016
10 C p. 145-168
24 p.
article
5 Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis Banwell, Emma
2016
10 C p. 123-126
4 p.
article
6 Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis Waldman, Amy T.
2016
10 C p. 73-78
6 p.
article
7 Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure Pau, Massimiliano
2016
10 C p. 187-191
5 p.
article
8 Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt Zakaria, Magd
2016
10 C p. 30-35
6 p.
article
9 Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings Kimiskidis, Vasilios K.
2016
10 C p. 192-197
6 p.
article
10 Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study Sundgren, M.
2016
10 C p. 36-43
8 p.
article
11 Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up Hersh, Carrie M.
2016
10 C p. 44-52
9 p.
article
12 Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis Freedman, Mark S.
2016
10 C p. 204-212
9 p.
article
13 Consanguinity and multiple sclerosis susceptibility: A case control study Maghzi, Helia
2016
10 C p. 179-180
2 p.
article
14 Corrigendum to ‘Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature’ [Mult. Scler. Relat. Disord. 9 (2016) 158–162] Grebenciucova, Elena
2016
10 C p. 213-
1 p.
article
15 Editors' Welcome Hawkes, Chris
2016
10 C p. A1-
1 p.
article
16 Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study Jensen, H.B.
2016
10 C p. 137-144
8 p.
article
17 Eleven episodes of recurrent optic neuritis of the same eye for 22 years eventually diagnosed as neuromyelitis optica spectrum disorder Yew, Yih Chian
2016
10 C p. 22-25
4 p.
article
18 Extratemporal herpes encephalitis during natalizumab treatment: A case report Haggiag, Shalom
2016
10 C p. 134-136
3 p.
article
19 Favorable outcome of interferon-beta associated thrombotic microangiopathy following treatment with corticosteroids, plasma exchange and rituximab: A case report Gerischer, Lea M.
2016
10 C p. 63-65
3 p.
article
20 Heart rate variability predicts the magnitude of heart rate decrease after fingolimod initiation Simula, Sakari
2016
10 C p. 86-89
4 p.
article
21 How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis Baker, David
2016
10 C p. 127-133
7 p.
article
22 Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort Thormann, Anja
2016
10 C p. 181-186
6 p.
article
23 Language disorders in multiple sclerosis: A systematic review Renauld, Stéphanie
2016
10 C p. 103-111
9 p.
article
24 Motor fatigability after low-intensity hand grip exercises in persons with multiple sclerosis Severijns, Deborah
2016
10 C p. 7-13
7 p.
article
25 Persian adaptation of a questionnaire of environmental risk factors in multiple sclerosis (EnvIMS-Q) Sahraian, Mohammad Ali
2016
10 C p. 82-85
4 p.
article
26 Physical activity in pediatric onset multiple sclerosis: Validating a questionnaire for clinical practice and research Kinnett-Hopkins, Dominique
2016
10 C p. 26-29
4 p.
article
27 Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab Roar, Malte
2016
10 C p. 116-122
7 p.
article
28 Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis Moccia, Marcello
2016
10 C p. 90-96
7 p.
article
29 Quality of life and its correlates in adolescent multiple sclerosis patients Ostojic, Slavica
2016
10 C p. 57-62
6 p.
article
30 Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis Longbrake, Erin E.
2016
10 C p. 198-203
6 p.
article
31 Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis Petersen, ER.
2016
10 C p. 66-72
7 p.
article
32 Successful treatment of paroxysmal ataxia and dysarthria in multiple sclerosis with levetiracetam Goodwin, Shikha J.
2016
10 C p. 79-81
3 p.
article
33 The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome Diker, Sevda
2016
10 C p. 14-21
8 p.
article
34 The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis Abdoli, Mohammad
2016
10 C p. 97-102
6 p.
article
35 The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait Pacifici, Ilaria
2016
10 C p. 174-178
5 p.
article
36 Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab Laursen, Julie Hejgaard
2016
10 C p. 169-173
5 p.
article
                             36 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands